Clinical Trials Logo

Seasonal Influenza clinical trials

View clinical trials related to Seasonal Influenza.

Filter by:

NCT ID: NCT01072799 Completed - Seasonal Influenza Clinical Trials

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Start date: October 2009
Phase: Phase 2
Study type: Interventional

This is a Phase 2 randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and immunogenicity of three dose levels (5µg, 15µg and 45µg HA) of the novel A (H1N1) influenza VLP vaccine as compared with a placebo in healthy adults (18 to 64 years of age).

NCT ID: NCT01011582 Completed - Seasonal Influenza Clinical Trials

Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza

Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of this research study is to collect information on problems that patients with the novel H1N1 influenza and/or the seasonal influenza experience. Novel H1N1 flu is also called the swine flu. Seasonal influenza is also called the regular flu. The purpose of this study is to collect information from patients who are infected with either the novel H1N1 or the seasonal flu and to determine what makes patients critically ill with these infections. The goal is to develop a registry that will aid investigators in determining specific markers that lead to development of severe illness in these infections.

NCT ID: NCT00958776 Terminated - Headache Clinical Trials

A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Start date: November 2009
Phase: Phase 3
Study type: Interventional

A Phase 3, multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of peramivir administered intravenously in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalized due to serious influenza.

NCT ID: NCT00957996 Completed - Fatigue Clinical Trials

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Start date: October 2009
Phase: Phase 3
Study type: Interventional

This is a Phase 3, open-label, randomized study of the antiviral activity, safety, and tolerability of intravenous Peramivir in hospitalized subjects with confirmed or suspected influenza infection.

NCT ID: NCT00956761 Completed - Seasonal Influenza Clinical Trials

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Start date: June 2009
Phase: Phase 2
Study type: Interventional

This is a trial for annual registration of the updated seasonal influenza vaccine formulation.

NCT ID: NCT00956449 Completed - Influenza Clinical Trials

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

Start date: June 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the antibody response to each of the three influenza vaccine strains included in the licensed seasonal flu vaccine, as measured by hemagglutination inhibition (HI) at 21 days post immunization in non−elderly and elderly subjects in compliance with the requirements of the current European Union (EU) recommendations for the evaluation of the immunogenicity for a new formulation of a licensed flu vaccine (CPMP/BWP/214/96).

NCT ID: NCT00945841 Completed - Seasonal Influenza Clinical Trials

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010

Start date: June 2009
Phase: Phase 3
Study type: Interventional

This study is an annual trial for registration of inactivated split influenza vaccine with strain composition for season 2009/2010.

NCT ID: NCT00943657 Completed - Influenza Clinical Trials

Yearly Strain Variation Study, 2009/2010

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Union (WHO/EU) recommendation for the 2009/2010 season for yearly licensing application.

NCT ID: NCT00903552 Completed - Seasonal Influenza Clinical Trials

Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)

Start date: May 2009
Phase: Phase 2
Study type: Interventional

This is a phase 2A randomized, double blind, placebo controlled trial to evaluate the safety and immunogenicity of a trivalent seasonal influenza virus-like particle (VLP) vaccine (recombinant) in healthy adults.

NCT ID: NCT00748813 Completed - Seasonal Influenza Clinical Trials

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Start date: June 2008
Phase: Phase 2
Study type: Interventional

Annual trial for registration influenza vaccine with the strain composition for season 2008/2009